Dr. Lori Beth Bennett, M.D./PH.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 301 Deinhard Ln, Mccall, ID 83638 Phone: 208-630-2450 Fax: 208-634-4055 |
Dr. Norman Paul Litchfield, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 301 Deinhard Ln, Mccall, ID 83638 Phone: 208-630-2450 Fax: 208-634-4055 |
News Archive
President Obama will warn health insurance executives at a White House meeting Tuesday against trying to increase premium rates before the new law takes effect, The New York Times reports. "The White House is concerned that health insurers will blame the new law for increases in premiums that are intended to maximize profits rather than covering claims."
Ipsen, a global biopharmaceutical group, today announced that its partner Roche has disclosed results of the phase III T-emerge 3 study in patients with diabetes with taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence. Taspoglutide originating from Ipsen's research is developed by Roche.
Effective today, TerraMedica has changed its name to Fortel Analytics to reflect their focus on managing healthcare fraud and abuse prevention through advancing new and innovative predictive solutions, analysis methods and analytical technology.
Purdue researchers have identified a new class of chemical insecticides that could provide a safer, more selective means of controlling mosquitoes that transmit key infectious diseases such as dengue, yellow fever and elephantiasis.
ProPublica: "Drug companies say the millions of dollars they pay physicians for speaking and consulting justly compensates them for the laudable work of educating their colleagues. But a series of lawsuits brought by former employees of those companies allege the money often was used for illegal purposes — financially rewarding doctors for prescribing their brand-name medications.
› Verified 9 days ago